多发性硬化合并抑郁与残疾加重的瑞典队列研究
该回顾性队列研究基于瑞典全国登记数据,纳入多发性硬化(MS)患者,分别以ICD-10诊断和抗抑郁药处方定义抑郁,采用Cox回归比较合并与不合并抑郁者的持续EDSS残疾里程碑风险。结果显示抑郁与残疾加重风险显著升高相关,抗抑郁药暴露者亦呈类似风险,提示需早期识别并治疗抑郁。
要点
- MS合并抑郁者达到持续EDSS 3.0、4.0、6.0的风险显著高于无抑郁者。
- 以抗抑郁药处方定义抑郁时,残疾加重风险同样升高。
- 临床应早期识别并适当治疗MS患者的抑郁。
核心结论
- MS合并抑郁者残疾加重风险显著升高。
- 该发现强调需早期识别并适当治疗MS患者的抑郁。
研究设计与样本
- 回顾性队列研究,链接瑞典MS登记、国家患者登记和处方药登记三个全国性登记数据。
- 队列1纳入MS登记中2001-2014年全部注册MS病例,抑郁定义为≥1个ICD-10抑郁编码。
- 队列2纳入MS登记中2005-2014年全部MS病例,抑郁定义为≥1次抗抑郁药处方配药。
- 采用Cox回归比较合并与不合并抑郁者达到持续EDSS 3.0、4.0、6.0里程碑的风险。
主要发现
- 队列1共5875例,502例(8.5%)有抑郁。
- 队列2共3817例,1289例(33.8%)被处方抗抑郁药。
- 抑郁者达到持续EDSS 3.0、4.0、6.0的风险比分别为1.50(95%CI 1.20-1.87)、1.79(95%CI 1.40-2.29)、1.89(95%CI 1.38-2.57)。
- 抗抑郁药暴露者达到持续EDSS 3.0、4.0、6.0的风险比分别为1.37(95%CI 1.18-1.60)、1.93(95%CI 1.61-2.31)、1.86(95%CI 1.45-2.40)。
临床怎么用
- 对MS患者应常规关注抑郁症状,早期识别并给予适当治疗。
- 合并抑郁的MS患者可能需要更密切的残疾进展监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Depression is common in multiple sclerosis (MS), but its impact on disability worsening has not yet been determined. We explored the risk of disability worsening associated with depression in a nationwide longitudinal cohort. METHODS: This retrospective cohort study used linked data from 3 Swedish nationwide registries: the MS Register, National Patient Register, and Prescribed Drug Register. Two incident cohorts were developed: cohort 1 included all registered cases of MS in the MS Registry (2001-2014) with depression defined as ≥1 ICD-10 code for depression; and cohort 2 comprised all cases of MS in the MS Registry (2005-2014) with depression defined as ≥1 prescription filled for an antidepressant. Cox regression models were used to compare the risk of reaching sustained disability milestone scores of 3.0, 4.0, and 6.0 on the Expanded Disability Status Scale (EDSS) between persons with MS with and without depression. RESULTS: Cohort 1 included 5,875 cases; 502 (8.5%) had depression. Cohort 2 had 3,817 cases; 1,289 (33.8%) were prescribed an antidepressant. Persons with depression were at a significantly higher risk of reaching sustained EDSS scores of 3.0, 4.0, and 6.0, with hazard ratios of 1.50 (95% confidence interval [CI] 1.20-1.87), 1.79 (95% CI 1.40-2.29), and 1.89 (95% CI 1.38-2.57), respectively. A similar increased risk among persons exposed to antidepressants was observed, with hazard ratios of 1.37 (95% CI 1.18-1.60), 1.93 (95% CI 1.61-2.31), and 1.86 (95% CI 1.45-2.40) for sustained EDSS scores of 3.0, 4.0, and 6.0, respectively. CONCLUSION: Persons with MS and comorbid depression had a significantly increased risk of disability worsening. This finding highlights the need for early recognition and appropriate treatment of depression in persons with MS.
引用
- Binzer S, McKay KA, Brenner P, et al. Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study. Neurology. 2019. PMID: 31704791. doi:10.1212/WNL.0000000000008617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。